Ionis Pharmaceuticals Nosedives After AstraZeneca Drops High Cholesterol Drug Test
Ionis stock tumbled Friday after partner AstraZeneca decided against sending their high cholesterol treatment into Phase 3 testing.
Ionis Pharmaceuticals Nosedives After AstraZeneca Drops High Cholesterol Drug Test
Ionis stock tumbled Friday after partner AstraZeneca decided against sending their high cholesterol treatment into Phase 3 testing.